Ledger.Open graph →
SEC Form D · filed October 16, 2025

Mekiri Bio, Inc

Offering
$2.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Debbie Lin · Boston, MAExecAnita Difazio · Boston, MAExecAaron Diantonio · Boston, MADirectorCorey Mccann · Louisville, KYDirectorDebbie Lin · Boston, MAExecAnita Difazio · Boston, MAExecAaron Diantonio · Boston, MADirectorCorey Mccann · Louisville, KYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗